Triethylamine → HCID 178477817, compound

HRID 588589Notes

Reaction equation

HRID 588589 reaction equation
[Cl:1][C:2]1[C:7]([C:8]2[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=2)=[N:6][N:5]=[C:4]2[NH:14][N:15]=[CH:16][C:3]=12.[Br:17]Br.C(N(CC)CC)C.C(=O)(O)[O-].[Na+]>C(Cl)(Cl)Cl.C(Cl)Cl>[Br:17][C:16]1[C:3]2[C:4](=[N:5][N:6]=[C:7]([C:8]3[CH:13]=[CH:12][CH:11]=[CH:10][CH:9]=3)[C:2]=2[Cl:1])[NH:14][N:15]=1

Participants

7

Procedure

A mixture of 4-chloro-5-phenyl-1H-pyrazolo[3,4-c]pyridazine (155 mg, 0.67 mmol), bromine (51 μL, 1 mmol) and triethylamine (98 μL, 0.7 mmol) in chloroform (4 mL) was stirred at room temperature for 1 h. Additional bromine (25 μL) and chloroform (4 mL) were added and the reaction mixture was stirred at room temperature for 4 h. Further bromine (25 μL) and triethylamine (98 μL) were added and the reaction mixture was stirred at room temperature for 16 h. The reaction mixture was diluted with CH2Cl2 and a sodium bicarbonate solution. The aqueous phase was extracted with CH2Cl2 and the combined organic phases were dried (phase separator cartridge) and concentrated in vacuo. The resultant residue was purified using chromatography (silica gel, ethyl acetate/isohexane 0:1 to 1:1), to provide Compound Ibb as a solid (97 mg).

Workup

  1. stirringthe reaction mixture was stirred at room temperature for 4 h
  2. stirringthe reaction mixture was stirred at room temperature for 16 h
  3. extractionThe aqueous phase was extracted with CH2Cl2
  4. customthe combined organic phases were dried (phase separator cartridge)
  5. concentrationconcentrated in vacuo
  6. customThe resultant residue was purified

Sources & evidence

ORD record
ord-e3eb881d2d574f1ea26f62d4adbe150b
Source dataset
uspto-grants-2016_01
Patent number
US09227976B2

Reaction notes

Loading…